Allen Carr’s Easyway to Quit Smoking Success Rate
The success rate at Allen Carr’s Easyway Centers is over 90 per cent *The success rate of the method is over 90% based on 3 month money-back guarantee provided at Allen Carr’s Easyway centers worldwide (for smoking cessation, alcohol, and drugs) and independent scientific studies indicate that even after 12 months the quit smoking success rate for the method remains over 50%. This is unprecedented in the field of addiction.
‘Long-term success of short smoking-cessation seminars supported by occupational health care’, H. Moshammer, M. Neuberger. Addictive Behaviors (2007). ‘Smoking cessation at the workplace: 1 year success of short seminars’ H.P Hutter, H. Moshammer, M.Neuberger. Internal Archives of Occupational Environmental Health (2005).
Allen Carr’s Easyway are currently undertaking Randomised Controlled Trials to prove that the success rate of the method is unrivalled., a success rate based on our 3 month money-back guarantee.
Independent scientific studies published in peer review journals indicate that even after 12 months the quit smoking success rate remains over 53% and 51% after 3 years per Addictive Behaviours in October 2006 and Long-term success of short smoking-cessation seminars supported by occupational health care, H. Moshammer, M. Neuberger. Addictive Behaviors (2007) Success Rate 51.4% after 3 years and Smoking cessation at the workplace: 1 year success of short seminars, H.P Hutter, H. Moshammer, M.Neuberger. Internal Archives of Occupational Environmental Health (2005) 40% (worse case) 55% (best estimate).
This is unprecedented in the field of smoking cessation
Comparing Allen Carr’s Easyway with other quit smoking methods
Believe it or not, there is no single resource for smokers to compare the success rates of various quit smoking methods. Given the amount of money that has been spent in this area of research, we find this odd.
The reason for this is that researchers do not compare methods head-to-head; they typically compare them to placebo, or to no treatment.
This enables manufacturers of Nicotine Replacement Therapy products, for example, to make claims such as NRT “doubles your chances” of quitting. However we believe that smokers are much more interested in the question: “Double them from what to what?”
We have compiled the table below to give you an indication of the relevant success rates.
Allen Carr’s Easyway are taking part in a number of randomised controlled trials comparing the method to existing National Health quit smoking services.
Success Ratios of Cessation Methods at 1 year
| Nicotine Replacement Therapy
|| 7% 2-10
|| 14% 2-10
|| 7% 2-10
|NHS Quit Smoking Services
|| 2.5% 11
|Allen Carr’s Easyway
90% at 3 months
50% at 1 year 12
The above table may appear to be nonsensical. It shows that the NHS quit smoking service has a lower success rate than a placebo! However, the research was performed by Cancer Research UK and other studies have also shown that NRT has performed below the placebo.
The table also shows that the NHS quit smoking service underperforms Nicotine Replacement Therapy, Champix and Zyban yet these are the very things that are prescribed by the service. It’s a confusing picture and it’s no surprise that the studies for the individual drugs are often funded by the pharmaceutical companies themselves.
Based on the above chart, with one exception, you would conclude that it is very difficult to quit smoking. Yet millions will confirm that that is not correct, in fact, it can be easy. The secret is choosing the right method.
We are currently undertaking further clinical trials to confirm the success rate of Allen Carr’s Easyway method.
Find the right program for you
- Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001118. DOI:10.1002/14651858.CD001118.pub2
- Stead LF. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012 Art. No.: CD000146. DOI: 10.1002/14651858.
- Hughes J, Rennard S. Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial. Nicotine & Tobacco Research Journal. September 2011
- Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000.
- Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001118. DOI:10.1002/14651858.CD001118.pub2.
- Wu P, Wilson K, Dimoulas P, et al. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006; 6: 300.
- Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006103. DOI: 10.1002/14651858.CD006103.pub2.
- Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD000031. DOI: 10.1002/14651858.CD000031.pub3.
- Crane R. The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician. Prim Care Clin Office Pract 2007; 34: 117-35.
- GlaxoSmithKline. Zyban SR Prescribing Information. May 2007. http://us.gsk.com/products/assets/us_zyban.pdf. Last accessed 25 June 07
- West R., May S., West M., Croghan E. & McEwen A. (2013). Performance of English quit smoking services in first 10 years: analysis of service monitoring data, BMJ, 347 (aug19 2) f4921-f4921. DOI: 10.1136/bmj.f4921
- 90% based on the money back guarantee. In a 2 to 5 year post seminar study the success rate was seen to be 51%. Moshammer H, Neuberger M, Kong term success of short smoking cessation seminars supported by occupational health care. Addictive Behaviours 32 (2007) 1486-1493